Annual EBITDA
$18.65 B
-$568.00 M-2.96%
31 December 2023
Summary:
Bristol-Myers Squibb annual earnings before interest, taxes, depreciation & amortization is currently $18.65 billion, with the most recent change of -$568.00 million (-2.96%) on 31 December 2023. During the last 3 years, it has risen by +$13.72 billion (+278.43%). BMY annual EBITDA is now -7.28% below its all-time high of $20.12 billion, reached on 31 December 2021.BMY EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$4.77 B
+$370.00 M+8.40%
30 September 2024
Summary:
Bristol-Myers Squibb quarterly earnings before interest, taxes, depreciation & amortization is currently $4.77 billion, with the most recent change of +$370.00 million (+8.40%) on 30 September 2024. Over the past year, it has dropped by -$79.00 million (-1.63%). BMY quarterly EBITDA is now -14.02% below its all-time high of $5.55 billion, reached on 31 March 2021.BMY Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$5.07 B
-$79.00 M-1.53%
30 September 2024
Summary:
Bristol-Myers Squibb TTM earnings before interest, taxes, depreciation & amortization is currently $5.07 billion, with the most recent change of -$79.00 million (-1.53%) on 30 September 2024. Over the past year, it has dropped by -$14.52 billion (-74.11%). BMY TTM EBITDA is now -74.79% below its all-time high of $20.12 billion, reached on 31 December 2021.BMY TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMY EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.0% | -1.6% | -74.1% |
| 3 y3 years | +278.4% | -8.4% | -36.2% |
| 5 y5 years | +174.8% | +176.1% | -34.3% |
BMY EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -7.3% | +278.4% | -13.0% | +155.8% | -74.8% | at low |
| 5 y | 5 years | -7.3% | +278.4% | -14.0% | +155.8% | -74.8% | +2.9% |
| alltime | all time | -7.3% | +1358.4% | -14.0% | +155.8% | -74.8% | +239.1% |
Bristol-Myers Squibb EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.77 B(+8.4%) | $5.07 B(-1.5%) |
| June 2024 | - | $4.40 B(-151.4%) | $5.15 B(-3.2%) |
| Mar 2024 | - | -$8.56 B(-292.2%) | $5.32 B(-72.5%) |
| Dec 2023 | $18.65 B(-3.0%) | $4.45 B(-8.2%) | $19.37 B(-1.1%) |
| Sept 2023 | - | $4.85 B(+6.1%) | $19.59 B(-1.2%) |
| June 2023 | - | $4.57 B(-16.7%) | $19.83 B(-1.4%) |
| Mar 2023 | - | $5.49 B(+17.4%) | $20.11 B(+4.6%) |
| Dec 2022 | $19.22 B(-4.5%) | $4.67 B(-8.3%) | $19.22 B(-0.4%) |
| Sept 2022 | - | $5.10 B(+5.0%) | $19.31 B(-0.6%) |
| June 2022 | - | $4.85 B(+5.6%) | $19.42 B(+1.4%) |
| Mar 2022 | - | $4.60 B(-3.4%) | $19.16 B(-4.7%) |
| Dec 2021 | $20.12 B(+308.2%) | $4.76 B(-8.7%) | $20.12 B(+153.0%) |
| Sept 2021 | - | $5.21 B(+13.4%) | $7.95 B(-0.6%) |
| June 2021 | - | $4.59 B(-17.2%) | $8.00 B(+0.7%) |
| Mar 2021 | - | $5.55 B(-175.0%) | $7.95 B(+61.2%) |
| Dec 2020 | $4.93 B(-33.2%) | -$7.41 B(-240.9%) | $4.93 B(-64.1%) |
| Sept 2020 | - | $5.26 B(+15.8%) | $13.72 B(+34.6%) |
| June 2020 | - | $4.54 B(+79.2%) | $10.19 B(+32.1%) |
| Mar 2020 | - | $2.54 B(+82.9%) | $7.72 B(+4.6%) |
| Dec 2019 | $7.38 B(+8.7%) | $1.39 B(-19.8%) | $7.38 B(-4.4%) |
| Sept 2019 | - | $1.73 B(-16.4%) | $7.72 B(-7.7%) |
| June 2019 | - | $2.07 B(-5.7%) | $8.36 B(+19.2%) |
| Mar 2019 | - | $2.19 B(+27.2%) | $7.01 B(+3.3%) |
| Dec 2018 | $6.79 B(+11.0%) | $1.73 B(-27.4%) | $6.79 B(+13.0%) |
| Sept 2018 | - | $2.38 B(+230.5%) | $6.01 B(+18.9%) |
| June 2018 | - | $719.00 M(-63.5%) | $5.05 B(-14.2%) |
| Mar 2018 | - | $1.97 B(+108.0%) | $5.89 B(-3.7%) |
| Dec 2017 | $6.12 B(-5.4%) | $946.00 M(-33.3%) | $6.12 B(-4.7%) |
| Sept 2017 | - | $1.42 B(-8.9%) | $6.42 B(-4.3%) |
| June 2017 | - | $1.56 B(-29.0%) | $6.71 B(-2.7%) |
| Mar 2017 | - | $2.19 B(+75.7%) | $6.89 B(+6.7%) |
| Dec 2016 | $6.46 B(+145.1%) | $1.25 B(-26.8%) | $6.46 B(+31.2%) |
| Sept 2016 | - | $1.71 B(-2.3%) | $4.92 B(+13.2%) |
| June 2016 | - | $1.75 B(-0.9%) | $4.35 B(+55.6%) |
| Mar 2016 | - | $1.76 B(-705.8%) | $2.80 B(+6.1%) |
| Dec 2015 | $2.64 B(-13.6%) | -$291.00 M(-125.7%) | $2.64 B(-12.8%) |
| Sept 2015 | - | $1.13 B(+490.1%) | $3.02 B(-1.2%) |
| June 2015 | - | $192.00 M(-88.0%) | $3.06 B(-12.0%) |
| Mar 2015 | - | $1.60 B(+1569.8%) | $3.48 B(+14.0%) |
| Dec 2014 | $3.05 B(-20.8%) | $96.00 M(-91.8%) | $3.05 B(-24.8%) |
| Sept 2014 | - | $1.17 B(+92.1%) | $4.06 B(+3.2%) |
| June 2014 | - | $609.00 M(-48.2%) | $3.93 B(-3.9%) |
| Mar 2014 | - | $1.18 B(+6.6%) | $4.09 B(+6.2%) |
| Dec 2013 | $3.85 B(+20.3%) | $1.10 B(+5.7%) | $3.85 B(+9.7%) |
| Sept 2013 | - | $1.04 B(+35.8%) | $3.51 B(+141.8%) |
| June 2013 | - | $769.00 M(-17.9%) | $1.45 B(-24.8%) |
| Mar 2013 | - | $937.00 M(+22.8%) | $1.93 B(-39.7%) |
| Dec 2012 | $3.20 B(-58.7%) | $763.00 M(-175.1%) | $3.20 B(-24.1%) |
| Sept 2012 | - | -$1.02 B(-181.4%) | $4.22 B(-41.3%) |
| June 2012 | - | $1.25 B(-43.5%) | $7.19 B(-9.8%) |
| Mar 2012 | - | $2.21 B(+23.9%) | $7.97 B(+2.8%) |
| Dec 2011 | $7.75 B(+13.6%) | $1.78 B(-8.9%) | $7.75 B(+3.6%) |
| Sept 2011 | - | $1.96 B(-3.6%) | $7.49 B(+1.8%) |
| June 2011 | - | $2.03 B(+2.0%) | $7.35 B(+3.0%) |
| Mar 2011 | - | $1.99 B(+31.1%) | $7.14 B(+4.6%) |
| Dec 2010 | $6.82 B(+5.1%) | $1.52 B(-16.7%) | $6.82 B(-0.4%) |
| Sept 2010 | - | $1.82 B(+0.3%) | $6.85 B(+0.4%) |
| June 2010 | - | $1.81 B(+8.6%) | $6.83 B(+1.1%) |
| Mar 2010 | - | $1.67 B(+8.2%) | $6.75 B(+4.0%) |
| Dec 2009 | $6.49 B(+10.0%) | $1.54 B(-13.8%) | $6.49 B(-4.4%) |
| Sept 2009 | - | $1.79 B(+3.0%) | $6.79 B(+6.2%) |
| June 2009 | - | $1.74 B(+23.1%) | $6.39 B(+4.1%) |
| Mar 2009 | - | $1.41 B(-23.2%) | $6.14 B(-1.9%) |
| Dec 2008 | $5.90 B(+33.5%) | $1.84 B(+31.8%) | $6.26 B(+8.6%) |
| Sept 2008 | - | $1.40 B(-6.0%) | $5.76 B(+5.6%) |
| June 2008 | - | $1.49 B(-2.8%) | $5.46 B(+8.5%) |
| Mar 2008 | - | $1.53 B(+13.7%) | $5.03 B(+11.8%) |
| Dec 2007 | $4.42 B(+33.4%) | $1.35 B(+23.5%) | $4.50 B(+33.6%) |
| Sept 2007 | - | $1.09 B(+2.9%) | $3.37 B(+13.6%) |
| June 2007 | - | $1.06 B(+5.9%) | $2.96 B(-6.5%) |
| Mar 2007 | - | $1.00 B(+365.6%) | $3.17 B(-4.3%) |
| Dec 2006 | $3.31 B(-29.0%) | $215.00 M(-68.8%) | $3.31 B(-16.3%) |
| Sept 2006 | - | $688.00 M(-45.7%) | $3.96 B(-11.4%) |
| June 2006 | - | $1.27 B(+10.8%) | $4.47 B(-1.9%) |
| Mar 2006 | - | $1.14 B(+32.8%) | $4.55 B(-2.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2005 | $4.67 B(-13.2%) | $861.00 M(-28.1%) | $4.67 B(-7.8%) |
| Sept 2005 | - | $1.20 B(-11.6%) | $5.06 B(-4.0%) |
| June 2005 | - | $1.35 B(+8.0%) | $5.27 B(-0.1%) |
| Mar 2005 | - | $1.25 B(-0.2%) | $5.28 B(-1.7%) |
| Dec 2004 | $5.37 B(-6.1%) | $1.26 B(-10.9%) | $5.37 B(-2.5%) |
| Sept 2004 | - | $1.41 B(+3.8%) | $5.51 B(-3.1%) |
| June 2004 | - | $1.36 B(+0.8%) | $5.68 B(-1.4%) |
| Mar 2004 | - | $1.35 B(-3.2%) | $5.76 B(+0.7%) |
| Dec 2003 | $5.72 B(+18.3%) | $1.39 B(-12.2%) | $5.72 B(+10.0%) |
| Sept 2003 | - | $1.59 B(+10.4%) | $5.20 B(+6.6%) |
| June 2003 | - | $1.44 B(+9.9%) | $4.88 B(+9.0%) |
| Mar 2003 | - | $1.31 B(+49.5%) | $4.48 B(-7.4%) |
| Dec 2002 | $4.84 B(-17.8%) | $874.00 M(-30.8%) | $4.84 B(-4.7%) |
| Sept 2002 | - | $1.26 B(+22.1%) | $5.08 B(-7.1%) |
| June 2002 | - | $1.03 B(-37.9%) | $5.46 B(-10.2%) |
| Mar 2002 | - | $1.67 B(+49.5%) | $6.08 B(-2.1%) |
| Dec 2001 | $5.89 B(-12.6%) | $1.11 B(-32.4%) | $6.21 B(-9.8%) |
| Sept 2001 | - | $1.65 B(-0.4%) | $6.89 B(-0.9%) |
| June 2001 | - | $1.66 B(-7.8%) | $6.96 B(-0.4%) |
| Mar 2001 | - | $1.79 B(+0.2%) | $6.99 B(+1.1%) |
| Dec 2000 | $6.73 B(+13.8%) | $1.79 B(+4.6%) | $6.91 B(+3.2%) |
| Sept 2000 | - | $1.71 B(+1.7%) | $6.69 B(+3.3%) |
| June 2000 | - | $1.69 B(-1.9%) | $6.48 B(+3.2%) |
| Mar 2000 | - | $1.72 B(+8.8%) | $6.28 B(+1.2%) |
| Dec 1999 | $5.92 B(+16.5%) | $1.58 B(+5.2%) | $6.20 B(+13.9%) |
| Sept 1999 | - | $1.50 B(+1.2%) | $5.45 B(-0.0%) |
| June 1999 | - | $1.48 B(-9.8%) | $5.45 B(+3.3%) |
| Mar 1999 | - | $1.64 B(+99.9%) | $5.28 B(+3.9%) |
| Dec 1998 | $5.08 B(+1.0%) | $822.00 M(-45.3%) | $5.08 B(-7.9%) |
| Sept 1998 | - | $1.50 B(+14.7%) | $5.52 B(+3.1%) |
| June 1998 | - | $1.31 B(-9.5%) | $5.35 B(+2.7%) |
| Mar 1998 | - | $1.45 B(+14.9%) | $5.21 B(+3.6%) |
| Dec 1997 | $5.03 B(+12.5%) | $1.26 B(-5.8%) | $5.03 B(+3.5%) |
| Sept 1997 | - | $1.34 B(+14.5%) | $4.86 B(+3.2%) |
| June 1997 | - | $1.17 B(-7.9%) | $4.71 B(+2.6%) |
| Mar 1997 | - | $1.27 B(+16.6%) | $4.59 B(+2.5%) |
| Dec 1996 | $4.47 B(+10.1%) | $1.09 B(-8.3%) | $4.47 B(+0.8%) |
| Sept 1996 | - | $1.19 B(+13.4%) | $4.44 B(+3.3%) |
| June 1996 | - | $1.05 B(-9.3%) | $4.30 B(+2.3%) |
| Mar 1996 | - | $1.15 B(+9.6%) | $4.20 B(+3.3%) |
| Dec 1995 | $4.06 B(+14.5%) | $1.05 B(+0.7%) | $4.06 B(+5.7%) |
| Sept 1995 | - | $1.04 B(+10.2%) | $3.85 B(+2.4%) |
| June 1995 | - | $948.00 M(-6.9%) | $3.76 B(+2.6%) |
| Mar 1995 | - | $1.02 B(+22.1%) | $3.66 B(+3.1%) |
| Dec 1994 | $3.55 B(+30.9%) | $834.00 M(-12.8%) | $3.55 B(+22.8%) |
| Sept 1994 | - | $956.00 M(+12.2%) | $2.89 B(+2.0%) |
| June 1994 | - | $852.00 M(-6.2%) | $2.83 B(+2.5%) |
| Mar 1994 | - | $908.00 M(+415.9%) | $2.77 B(+2.0%) |
| Dec 1993 | $2.71 B(+20.2%) | $176.00 M(-80.4%) | $2.71 B(+15.5%) |
| Sept 1993 | - | $899.00 M(+15.0%) | $2.35 B(+0.7%) |
| June 1993 | - | $782.00 M(-8.4%) | $2.33 B(+1.8%) |
| Mar 1993 | - | $854.00 M(-554.3%) | $2.29 B(+1.5%) |
| Dec 1992 | $2.25 B(-25.1%) | -$188.00 M(-121.3%) | $2.25 B(-26.8%) |
| Sept 1992 | - | $883.00 M(+19.3%) | $3.08 B(+1.1%) |
| June 1992 | - | $740.00 M(-9.8%) | $3.05 B(-0.2%) |
| Mar 1992 | - | $820.00 M(+28.3%) | $3.05 B(+1.4%) |
| Dec 1991 | $3.01 B(+14.4%) | $639.00 M(-24.7%) | $3.01 B(+3.6%) |
| Sept 1991 | - | $849.00 M(+14.0%) | $2.91 B(+2.6%) |
| June 1991 | - | $745.00 M(-4.4%) | $2.83 B(+2.9%) |
| Mar 1991 | - | $779.00 M(+45.9%) | $2.75 B(+4.6%) |
| Dec 1990 | $2.63 B(+105.9%) | $534.00 M(-31.2%) | $2.63 B(-172.2%) |
| Sept 1990 | - | $776.00 M(+16.5%) | -$3.65 B(+73.4%) |
| June 1990 | - | $666.00 M(+1.4%) | -$2.10 B(+300.6%) |
| Mar 1990 | - | $657.00 M(-111.4%) | -$525.00 M(-148.5%) |
| Dec 1989 | $1.28 B(-34.6%) | -$5.75 B(-347.7%) | $1.08 B(-50.4%) |
| Sept 1989 | - | $2.32 B(+3.4%) | $2.19 B(+6.0%) |
| June 1989 | - | $2.24 B(-0.9%) | $2.06 B(+7.5%) |
| Mar 1989 | - | $2.27 B(-148.8%) | $1.92 B(+8.4%) |
| Dec 1988 | $1.96 B(+20.1%) | -$4.64 B(-311.5%) | $1.77 B(-20.0%) |
| Sept 1988 | - | $2.20 B(+4.5%) | $2.21 B(+16.1%) |
| June 1988 | - | $2.10 B(-0.8%) | $1.91 B(+12.5%) |
| Mar 1988 | - | $2.12 B(-150.4%) | $1.69 B(+15.5%) |
| Dec 1987 | $1.63 B | -$4.20 B(-322.4%) | $1.47 B(-74.1%) |
| Sept 1987 | - | $1.89 B(0.0%) | $5.67 B(+50.0%) |
| June 1987 | - | $1.89 B(0.0%) | $3.78 B(+100.0%) |
| Mar 1987 | - | $1.89 B | $1.89 B |
FAQ
- What is Bristol-Myers Squibb annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb annual EBITDA year-on-year change?
- What is Bristol-Myers Squibb quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly EBITDA year-on-year change?
- What is Bristol-Myers Squibb TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb TTM EBITDA year-on-year change?
What is Bristol-Myers Squibb annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of BMY is $18.65 B
What is the all time high annual EBITDA for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual earnings before interest, taxes, depreciation & amortization is $20.12 B
What is Bristol-Myers Squibb annual EBITDA year-on-year change?
Over the past year, BMY annual earnings before interest, taxes, depreciation & amortization has changed by -$568.00 M (-2.96%)
What is Bristol-Myers Squibb quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of BMY is $4.77 B
What is the all time high quarterly EBITDA for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly earnings before interest, taxes, depreciation & amortization is $5.55 B
What is Bristol-Myers Squibb quarterly EBITDA year-on-year change?
Over the past year, BMY quarterly earnings before interest, taxes, depreciation & amortization has changed by -$79.00 M (-1.63%)
What is Bristol-Myers Squibb TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of BMY is $5.07 B
What is the all time high TTM EBITDA for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high TTM earnings before interest, taxes, depreciation & amortization is $20.12 B
What is Bristol-Myers Squibb TTM EBITDA year-on-year change?
Over the past year, BMY TTM earnings before interest, taxes, depreciation & amortization has changed by -$14.52 B (-74.11%)